BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9646644)

  • 21. [Clinical significance of bone scintigraphy for early detection of bone metastasis from breast cancer].
    Wada T; Hohjoh T; Matunami N; Yamato M; Kadota K; Morikawa E; Hara S; Matsuda T; Yasutomi M
    Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):781-5. PubMed ID: 2778373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone scintigraphy in the evaluation of cancer.
    Gupta V
    Kathmandu Univ Med J (KUMJ); 2005; 3(3):243-8. PubMed ID: 18650585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Scintigraphy in breast cancer].
    Morita R; Fukunaga M; Otsuka N
    Gan No Rinsho; 1986 Jan; Suppl():163-76. PubMed ID: 3959327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of skeletal scintigraphy in the follow-up of breast cancer].
    Langhammer HR; Sondershaus S; Lauer O; Steuer G; Bauer R
    Fortschr Med; 1983 Mar; 101(10):429-34. PubMed ID: 6840646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Staging of prostatic carcinoma with radionuclide bone scintigraphy and lymphography.
    Hayward SJ; McIvor J; Burdge AH; Jewkes RF; Williams G
    Br J Radiol; 1987 Jan; 60(709):79-81. PubMed ID: 3814999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bone scintigraphy in the preoperative determination of the stage of breast cancer].
    Denisov LE; Iarygin LM; Ermolaeva EV; Zhuravleva LI
    Med Radiol (Mosk); 1984 Jul; 29(7):5-8. PubMed ID: 6087080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience.
    Hathaway PB; Mankoff DA; Maravilla KR; Austin-Seymour MM; Ellis GK; Gralow JR; Cortese AA; Hayes CE; Moe RE
    Radiology; 1999 Mar; 210(3):807-14. PubMed ID: 10207485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancer.
    Vogel CL; Schoenfelder J; Shemano I; Hayes DF; Gams RA
    J Clin Oncol; 1995 May; 13(5):1123-8. PubMed ID: 7537797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skeletal Scintigraphy.
    Montilla-Soler JL; Makanji R
    Cancer Control; 2017 Apr; 24(2):137-146. PubMed ID: 28441368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of bone metastasis: recent comparative studies of imaging modalities.
    Talbot JN; Paycha F; Balogova S
    Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):374-410. PubMed ID: 21738113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of nuclear medicine in monitoring treatment in skeletal malignancy.
    Cook GJ; Fogelman I
    Semin Nucl Med; 2001 Jul; 31(3):206-11. PubMed ID: 11430527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Routine bone scanning in patients with T1 and T2 breast cancer: a waste of money.
    Yeh KA; Fortunato L; Ridge JA; Hoffman JP; Eisenberg BL; Sigurdson ER
    Ann Surg Oncol; 1995 Jul; 2(4):319-24. PubMed ID: 7552621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of nuclear medicine in the diagnosis of cancer of unknown origin.
    Demir H; Berk F; Raderer M; Plowman PN; Lassen U; Daugaard G; Clausen M; Bohuslavizki KH; Peters M; Harmer C; Malamitsi J; Aktolun C
    Q J Nucl Med Mol Imaging; 2004 Jun; 48(2):164-73. PubMed ID: 15243411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The diagnostic utility of the flare phenomenon on bone scintigraphy in staging prostate cancer.
    Cook GJ; Venkitaraman R; Sohaib AS; Lewington VJ; Chua SC; Huddart RA; Parker CC; Dearnaley DD; Horwich A
    Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):7-13. PubMed ID: 20697891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What do breast cancer patients benefit from staging bone scintigraphy?
    Koizumi M; Yoshimoto M; Kasumi F; Ogata E
    Jpn J Clin Oncol; 2001 Jun; 31(6):263-9. PubMed ID: 11463804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The current status of bone scintigraphy in malignant diseases.
    Dasgeb B; Mulligan MH; Kim CK
    Semin Musculoskelet Radiol; 2007 Dec; 11(4):301-11. PubMed ID: 18324595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear medicine in primary bone tumors.
    Focacci C; Lattanzi R; Iadeluca ML; Campioni P
    Eur J Radiol; 1998 May; 27 Suppl 1():S123-31. PubMed ID: 9652512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An introduction to Na(18)F bone scintigraphy: basic principles, advanced imaging concepts, and case examples.
    Bridges RL; Wiley CR; Christian JC; Strohm AP
    J Nucl Med Technol; 2007 Jun; 35(2):64-76; quiz 78-9. PubMed ID: 17496010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiologic diagnosis of bone metastases.
    Rosenthal DI
    Cancer; 1997 Oct; 80(8 Suppl):1595-607. PubMed ID: 9362427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow scintigraphy in breast cancer.
    Bourgeois P; Gassavelis C; Malarme M; Feremans W; Frühling J
    Nucl Med Commun; 1989 Jun; 10(6):389-400. PubMed ID: 2788844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.